Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
NCT06241781
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
83
Enrollment
INDUSTRY
Sponsor class
Conditions
Adult
Interventions
BIOLOGICAL:
GT101 injection
DRUG:
Gemcitabine injection
Sponsor
Grit Biotechnology